Venous Thromboembolism clinical trials
23 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
- REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- Apixaban in Thrombocytopenia
- Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
- Excretion of Rivaroxaban in Human Breast Milk
- Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
- Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
- Evaluation of the SCALED (SCaling AcceptabLE cDs)
- Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- Computerized Registry of Patients With Venous Thromboembolism (RIETE)
- Filter Initial & Long Term Evaluation After Placement and Retrieval Registry
- Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
- PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
- Aspiration Thrombectomy Using the Symphony or Prodigy System
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).
- Restarting Anticoagulation After Traumatic Intracranial Hemorrhage
- Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
- Warfarin Patient Self-management Implementation in the US Healthcare System
- Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Venous Thromboembolism” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.